Sun Pharma Advanced [SPARC] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sun Pharma Advanced Research Company Ltd. wins in 2 metrics, Divi's Laboratories Ltd. wins in 16 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sun Pharma Advanced Research Company Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) -13.65 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio -13.55 10.82 Divi's Laboratories Ltd.
Debt-to-Equity Ratio -1.21 0.58 Divi's Laboratories Ltd.
PEG Ratio -11.15 4.63 Divi's Laboratories Ltd.
EV/EBITDA -22.27 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) -53.22% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) -700.71% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) N/A 29.65% N/A
Return on Equity 157.88% 14.64% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) -102.08% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-3.71B $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 34.88% -0.43% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 87.98 16.18 Divi's Laboratories Ltd.
Enterprise Value $50.87B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 95.73 15.86 Divi's Laboratories Ltd.
Gross Profit Margin (TTM) -59.53% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $2 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $-8.25 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.19 0.19 Divi's Laboratories Ltd.

Sun Pharma Advanced Research Company Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

SPARC
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Sun Pharma Advanced Research Company Ltd. vs Divi's Laboratories Ltd.

MetricSPARCDIVISLAB
Market Information
Market Cap i₹46.75B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,401,062253,443
90 Day Avg. Volume i2,083,443283,911
Last Close₹229.03₹6,608.50
52 Week Range₹108.00 - ₹248.75₹5,636.50 - ₹7,071.50
% from 52W High-7.93%-6.55%
All-Time High₹875.00 (Apr 24, 2006)₹7,071.50 (Jul 08, 2025)
% from All-Time High-73.83%-6.55%
Growth Metrics
Quarterly Revenue Growth-0.43%0.12%
Quarterly Earnings Growth-0.43%-0.01%
Financial Health
Profit Margin (TTM) i-0.53%0.24%
Operating Margin (TTM) i-7.01%0.30%
Return on Equity (TTM) i1.58%0.15%
Debt to Equity (MRQ) i-1.210.58
Cash & Liquidity
Book Value per Share (MRQ)₹-10.63₹580.95
Cash per Share (MRQ)₹0.03₹122.95
Operating Cash Flow (TTM) i₹-3,484,287,000₹19.67B
Levered Free Cash Flow (TTM) i₹-3,425,094,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Sun Pharma Advanced Research Company Ltd. vs Divi's Laboratories Ltd.

MetricSPARC (Apr 22, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-13.6567.11
Forward P/E i2.6053.75
PEG Ratio i-11.154.63
Price to Sales (TTM) i87.9816.18
Price to Book (MRQ) i-13.5510.82
Market Capitalization
Market Capitalization i₹46.75B₹1.69T
Enterprise Value i₹50.87B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i95.7315.86
Enterprise to EBITDA i-22.2748.63
Risk & Other Metrics
Beta i0.190.19
Book Value per Share (MRQ) i₹-10.63₹580.95

Financial Statements Comparison: Sun Pharma Advanced Research Company Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSPARC (2025)DIVISLAB (2025)
Revenue/Sales i717.66M93.25B
Cost of Goods Sold i1.10B38.70B
COGS % of Revenue i153.2%41.5%
Gross Profit i-381.94M54.55B
Gross Margin i-53.2%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i-3.34B25.71B
Operating Margin i-465.5%27.6%
EBITDA i-3.23B33.19B
EBITDA Margin i-450.0%35.6%
Pre-Tax Income i-3.43B29.16B
Pre-Tax Income % of Revenue i-477.6%31.3%
Income Tax i-2.72M7.25B
Income Tax % of Revenue i-0.4%7.8%
Net Income (Profit) i-3.43B21.91B
Profit Margin i-477.3%23.5%

Balance Sheet & Liquidity Metrics

MetricSPARC (2025)DIVISLAB (2025)
Cash & Equivalents i19.64M4.15B
Total Current Assets i261.97M100.81B
Total Current Assets % of Revenue i36.5%108.1%
Total Current Liabilities i3.74B14.52B
Total Current Liabilities % of Revenue i521.5%15.6%
Long-Term Debt i1.07B20.00M
Long-Term Debt % of Revenue i149.0%0.0%
Total Shareholders Equity i-2.17B149.69B
Retained Earnings i-23.22B134.00B
Retained Earnings % of Revenue i-3,235.0%143.7%
Property, Plant & Equipment i178.02M3.19B

Cash Flow Statement Comparison

MetricSPARC (2025)DIVISLAB (2025)
Operating Cash Flow i-3.48B19.67B
Operating Cash Flow % of Revenue i-485.5%21.1%
Capital Expenditures i-97.45M-14.38B
Free Cash Flow i-3.71B2.15B
FCF Margin i-516.4%2.3%
Debt Repayment i-3.69BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSPARCDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i324.52M265.47M
Float Shares i91.32M117.72M
% Held by Insiders i72.96%52.04%
% Held by Institutions i2.56%28.65%
% Held by Public i24.48%19.31%

Dividend Analysis & Yield Comparison: Sun Pharma Advanced Research Company Ltd. vs Divi's Laboratories Ltd.

MetricSPARCDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025